← Leaderboards
Margaret J Lange
University Of Missouri-Columbia
$1,100,952
Attributed
$1,382,369
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $384K · FY2010–25$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,382,369 · 4
By mechanism
R21$845,458 · 2
R56$384,037 · 1
F32$152,874 · 1
Top collaborators
- Donald H Burke2 shared
- Stefan G Sarafianos2 shared
Most similar at University Of Missouri-Columbia
Same institution · by research overlap
- Bumsuk Hahm$6,887,002
- Marc C Johnson$4,450,491
- David J. Pintel$14,168,814
- James Amos-Landgraf$1,373,316
- Craig L Franklin$12,821,302
Others in their field
Top investigators on “Aptamer”
- F F Choobineh · University Of Nebraska$22,000,000
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Bruce Alan Sullenger · Children'S Hosp Of Philadelphia$16,344,327
- John Joseph Rossi · City Of Hope National Medical Center$16,108,485
- John T Lis · Cornell University$13,281,362
- Judy Lieberman · Boston Children'S Hospital$12,052,879
Research focus
AptamerVirusCellsFutureNucleic AcidsAnti-Hiv AgentsGenerationsLinkMediatingEventBindingHiv-1ComplexBinding SitesImmune ResponseIntegration Host FactorsDimerDefectBiologyEquilibriumDissociationCapsidCapsid ProteinsDrug Resistance
Grant awards (8)
Aptamers that discriminate among HIV-1 capsid assembly states$227,708
R21 · FY2025 · AI · contact PI
Aptamers that discriminate among HIV-1 capsid assembly states$195,625
R21 · FY2024 · AI · contact PI
Aptamer tools for dissecting HIV-1 capsid function and identifying accessible, biologically relevant interaction surfaces.$384,037
R56 · FY2022 · AI · contact PI
RNA Aptamers that Differentiate Among HIV-1 Capsid Assembly States$230,250
R21 · FY2017 · AI · contact PI
RNA Aptamers that Differentiate Among HIV-1 Capsid Assembly States$191,875
R21 · FY2016 · AI · contact PI
Bioactivity of Aptamers Targeted to HIV Reverse Transcriptase$53,942
F32 · FY2012 · AI · contact PI
Bioactivity of Aptamers Targeted to HIV Reverse Transcriptase$51,326
F32 · FY2011 · AI · contact PI
Bioactivity of Aptamers Targeted to HIV Reverse Transcriptase$47,606
F32 · FY2010 · AI · contact PI